Pneumococcal conjugate second or third-dose vaccines (PCVc) in Kiribati
Kiribati: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 87.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Kiribati, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Kiribati is 87.0%, measured in 2025.
Compared with earlier readings it is down 6.5% on the previous year and up 11.5% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Kiribati peaked at 97.0% in 2019 and was at its lowest, 0.0%, in 2008.
That places Kiribati 86th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Kiribati, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 40.0% | — |
| 2014 | 57.0% | +42.5% |
| 2015 | 78.0% | +36.8% |
| 2016 | 79.0% | +1.3% |
| 2017 | 91.0% | +15.2% |
| 2018 | 94.0% | +3.3% |
| 2019 | 97.0% | +3.2% |
| 2020 | 91.0% | -6.2% |
| 2021 | 90.0% | -1.1% |
| 2022 | 91.0% | +1.1% |
| 2023 | 91.0% | +0.0% |
| 2024 | 93.0% | +2.2% |
| 2025 | 87.0% | -6.5% |
Kiribati compared with similar countries
- Kiribati's 87.0% is above the median for lower middle income countries, which is 84.0%, 1.0× the median. (47 countries reporting)
- Kiribati's 87.0% is above the median for East Asia & Pacific, which is 81.0%, 1.1× the median. (30 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Kiribati changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2014 | +42.5% | 40.0% | 57.0% |
| 2015 | +36.8% | 57.0% | 78.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 53.6% | 0.0% | 97.0% | 10 |
| 2020s | 90.5% | 87.0% | 93.0% | 6 |
Countries ranked near Kiribati
- 86 Kenya 87.0% compare
- 86 Dominican Republic 87.0% compare
- 86 Netherlands 87.0% compare
- 86 Niger 87.0% compare
- 86 Lithuania 87.0% compare
More health data for Kiribati
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7209 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,076 deaths per 1,000 people (2090)
- Number of infants who die before age 1 34 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.3672 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0576 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3464 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Kiribati?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Kiribati was 87.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Kiribati?
- The highest recorded value was 97.0% in 2019.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Kiribati?
- The lowest recorded value was 0.0% in 2008.
- How does Kiribati rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Kiribati ranks 86th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Kiribati?
- Over the last ten years it is up 11.5%. The long-run trend across the full record is volatile.
- Where does this Kiribati data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).